Procoagulant Soluble Tissue Factor Is Released From Endothelial Cells in Response to Inflammatory Cytokines

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Circulation Research

• Publication date

  2005-06-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.RES.0000171805.24799.faPMID 15920023
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association of tissue-factor upregulation in squamous-cell carcinoma of the lung with increased tissue factor in circulating blood.

  2005cited by this paper
• Alterations in myocardial tissue factor expression and cellular localization in dilated cardiomyopathy.

  2005cited by this paper
• p38 MAPK mediates TNF-induced apoptosis in endothelial cells via phosphorylation and downregulation of Bcl-x(L).

  2004cited by this paper
• Interleukin-6 Induces Oxidative Stress and Endothelial Dysfunction by Overexpression of the Angiotensin II Type 1 Receptor

  2004cited by this paper
• Endothelial function and proinflammatory cytokines in patients with ischemic heart disease and dilated cardiomyopathy.

  2004cited by this paper
• [Rheumatoid arthritis, inflammation, and atherosclerosis].

  2004cited by this paper
• Active tissue factor in blood?

  2004cited by this paper
• Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein

  2003cited by this paper
• All-trans retinoic acid modulates microvascular endothelial cell hemostatic properties.

  2003cited by this paper
• Pro‐ and non‐coagulant forms of non‐cell‐bound tissue factor in vivo

  2003cited by this paper
• Antigenic characterization of endothelial cell‐derived microparticles and their detection ex vivo

  2003cited by this paper
• Angiopoietin‐1 negatively regulates expression and activity of tissue factor in endothelial cells

  2002cited by this paper
• Relationships between brachial artery flow mediated dilation and carotid artery intima-media thickness in patients with suspected coronary artery disease.

  2002cited by this paper
• Effect of Intradermal Tumor Necrosis Factor-α-induced Inflammation on Coagulation Factors in Dermal Vessel Endothelium

  2001cited by this paper
• Interleukin-6 Production by Endothelial Cells via Stimulation of Protease-Activated Receptors Is Amplified by Endotoxin and Tumor Necrosis Factor-α

  2001cited by this paper
• Circulating tissue factor and thrombosis

  2000cited by this paper
• Tissue factor, the blood, and the arterial wall.

  2000cited by this paper
• The Mkk3/6-p38–Signaling Cascade Alters the Subcellular Distribution of Hnrnp A1 and Modulates Alternative Splicing Regulation

  2000cited by this paper
• Release of active tissue factor by human arterial smooth muscle cells.

  2000cited by this paper
• Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor.

  2000cited by this paper
• Blood-borne tissue factor: another view of thrombosis.

  1999cited by this paper
• Tissue factor pathway inhibitor.

  1999cited by this paper
• Human Atheromatous Plaque Extracts Induce Tissue Factor Activity (TFa) in Monocytes and also Express Constitutive TFa

  1999cited by this paper
• Endothelial activation and cytokine expression in human acute cardiac allograft rejection

  1998cited by this paper
• Tissue Factor Pathway Inhibitor

  1995cited by this paper
• Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors.

  1994cited by this paper
• General splicing factor SF2/ASF promotes alternative splicing by binding to an exonic splicing enhancer.

  1993cited by this paper
• Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor.

  1989cited by this paper
• Tissue factor and hemostasis.

  1988cited by this paper

• Procoagulant Extracellular Vesicles Increase Neuronal Tau expression, Metabolism and Processing Through Tissue Factor and Protease Activated Receptor 2

  2026cites this paper
• 7,4′‐dimethoxy‐3‐hydroxyflavone, a protease‐activated receptor 4 (PAR4) inhibitor with antioxidant activity, ameliorates diabetic endothelial dysfunction

  2025cites this paper
• Augmentation of immunothrombosis as a key mechanism underlying JAK inhibition associated hypercoagulability in rheumatoid arthritis.

  2025cites this paper
• Venous Thromboembolic Events in Cancer Immunotherapy: A Narrative Review

  2025cites this paper
• Improvement in radiologic findings over time is associated with increased survival in patients with viral ARDS requiring extracorporeal membrane oxygenation

  2025cites this paper
• Flavivirus Nonstructural Protein 1‑Driven Coagulation via Tissue Factor-Bearing Microvesicles: A Pilot Study

  2025cites this paper
• Interplay of genetic and clinical factors in cancer-associated thrombosis: Deciphering the prothrombotic landscape of colorectal cancer

  2025cites this paper
• Challenging the notion of endothelial infection by SARS-CoV-2: insights from the current scientific evidence

  2025cites this paper
• Immobilized IgG-containing immune complexes require platelets to recruit neutrophils during inflammation

  2025cites this paper
• Update on Tissue Factor Detection in Blood in 2024: A Narrative Review

  2024cites this paper
• Predictive nomogram for ischemic stroke risk in clear cell renal cell carcinoma patients

  2024cites this paper
• Ponatinib Induces a Procoagulant Phenotype in Human Coronary Endothelial Cells via Inducing Apoptosis

  2024cites this paper
• Cardiovascular Disease and Thrombosis: Intersections with the Immune System, Inflammation, and the Coagulation System.

  2024cites this paper
• Coagulation abnormalities associated with CAR‐T‐cell therapy in haematological malignancies: A review

  2024cites this paper
• Extracellular vesicles in fresh frozen plasma and cryoprecipitate: Impact on in vitro endothelial cell viability

  2024cites this paper
• Potential utility of a multi-component coagulation factor panel to calculate MELD scores and assess the risk of portal vein thrombosis in chronic liver disease

  2023cites this paper
• Elevated Levels of Procoagulant Microvesicles and Tissue-Factor Bearing Microvesicles in Malaria Patients

  2023cites this paper
• Inflammatory Progression in Patients Undergoing Extracorporeal Membrane Oxygenation.

  2023cites this paper
• Extracellular vesicles derived from endothelial cells modulate macrophage phenotype in vitro

  2023cites this paper
• Molecular mechanism by which spider-driving peptide potentiates coagulation factors.

  2023cites this paper
• New positive β strand RNA virus is causes of diabetes and other disorders.

  2023cites this paper
• Long COVID-19 Pathophysiology: What Do We Know So Far?

  2023cites this paper
• Endothelial dysfunction and immunothrombosis in sepsis

  2023influential citation
• Role of pyroptosis in hemostasis activation in sepsis

  2023cites this paper
• Long COVID: pathophysiological factors and abnormalities of coagulation

  2023cites this paper
• Post-transcriptional control of haemostatic genes: mechanisms and emerging therapeutic concepts in thrombo-inflammatory disorders

  2023cites this paper
• Thrombosis in Acute Promyelocytic Leukemia: The Current Understanding

  2023cites this paper
• Diabetes and COVID-19; A Bidirectional Interplay

  2022cites this paper
• Physiological Changes in Subjects Exposed to Accidental Hypothermia: An Update

  2022cites this paper
• The Cholinergic Anti-inflammatory Pathway in Humans: State-of-the-Art Review and Future Directions.

  2022cites this paper
• Association between COVID-19 Diagnosis and Coronary Artery Thrombosis: A Narrative Review

  2022cites this paper
• Tissue factor in COVID-19-associated coagulopathy

  2022cites this paper
• Procoagulant Microvesicles in COVID-19 Patients: Possible Modulators of Inflammation and Prothrombotic Tendency

  2022cites this paper
• Cerebral Blood Flow in Predator Stress-Resilient and -Susceptible Rats and Mechanisms of Resilience

  2022cites this paper
• The interplay between inflammation and thrombosis in COVID-19: Mechanisms, therapeutic strategies, and challenges

  2022cites this paper
• Transcriptomic Profiling of Femoral Veins in Deep Vein Thrombosis in a Porcine Model

  2021cites this paper
• Mechanisms of immunothrombosis in COVID-19

  2021cites this paper
• Mechanisms of COVID-19 thrombosis in an inflammatory environment and new anticoagulant targets.

  2021cites this paper
• Ischemic Stroke in Patients with Cancer: a Retrospective Cross-Sectional Study

  2021cites this paper
• Type 1 Diabetes Mellitus in the SARS-CoV-2 Pandemic: Oxidative Stress as a Major Pathophysiological Mechanism Linked to Adverse Clinical Outcomes

  2021cites this paper
• Vascular endothelial Tissue Factor contributes to trimethylamine N-oxide-enhanced arterial thrombosis.

  2021cites this paper
• Changes in the coagulation parameters in dogs with protein-losing enteropathy between before and after treatment

  2021cites this paper
• Fundamentals in Covid-19-Associated Thrombosis: Molecular and Cellular Aspects

  2021cites this paper
• Advocacy of targeting protease‐activated receptors in severe coronavirus disease 2019

  2021cites this paper
• The pleiotropic effects of antithrombotic drugs in the metabolic-cardiovascular-neurodegenerative disease continuum: impact beyond reduced clotting.

  2021cites this paper
• Systemic Immune-Inflammation Index for Predicting the Prognosis of Critically Ill Patients with Acute Pancreatitis

  2021cites this paper
• Functional Characteristics and Regulated Expression of Alternatively Spliced Tissue Factor: An Update

  2021cites this paper
• Melanoma Cell Adhesion Molecule, CD146: A Major Actor and Target in Physiopathology

  2021cites this paper
• The Impact of the Renin-Angiotensin-Aldosterone System on Inflammation, Coagulation, and Atherothrombotic Complications, and to Aggravated COVID-19

  2021cites this paper
• Lung Epithelial Cell Transcriptional Regulation as a Factor in COVID-19–associated Coagulopathies

  2021cites this paper
• COVID-19 and Extracorporeal Membrane Oxygenation.

  2021cites this paper
• The impact of COVID-19 on the retina: clinical features and management considerations

  2021cites this paper
• Inflammatory Mechanisms Contributing to Endothelial Dysfunction

  2021cites this paper
• Thrombosis in Psoriasis: Cutaneous Cytokine Production as a Potential Driving Force of Haemostatic Dysregulation and Subsequent Cardiovascular Risk

  2021cites this paper
• The Many Faces of Cytokine Release Syndrome-Related Coagulopathy

  2021cites this paper
• Differential procoagulatory response of microvascular, arterial and venous endothelial cells upon inflammation in vitro.

  2021cites this paper
• Cancer-Related Venous Thromboembolism: From Pathogenesis to Risk Assessment

  2021cites this paper
• Prothrombotic genotypes and risk of venous thromboembolism in occult cancer.

  2021cites this paper
• Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses

  2020cites this paper
• Mechanisms and biomarkers of cancer-associated thrombosis: Cancer thrombosis mechanisms and biomarkers.

  2020cites this paper
• Preceding infection and risk of stroke: An old concept revived by the COVID-19 pandemic

  2020cites this paper
• Unique transcriptional changes in coagulation cascade genes in SARS-CoV-2-infected lung epithelial cells: A potential factor in COVID-19 coagulopathies

  2020cites this paper
• Metformin Is Associated with Reduced Tissue Factor Procoagulant Activity in Patients with Poorly Controlled Diabetes

  2020cites this paper
• CD146-Positive Tumors are Associated with Venous Thromboembolism

  2020cites this paper
• Pre-Existing Cytokine and NLRP3 Inflammasome Activation and Increased Vascular Permeability in Diabetes: A Possible Fatal Link With Worst COVID-19 Infection Outcomes?

  2020cites this paper
• Sepsis Produces Microthrombosis and Not Coagulation: Implications for Sepsis Therapy

  2020cites this paper
• Elevated levels of procoagulant microvesicles in patients with dengue fever

  2020cites this paper
• Consumptive coagulopathy of severe yellow fever occurs independently of hepatocellular tropism and massive hepatic injury

  2020cites this paper
• Immune Mechanisms in Cardiovascular Diseases Associated With Viral Infection

  2020cites this paper
• COVID-19 Associated Ischemic Stroke and Hemorrhagic Stroke: Incidence, Potential Pathological Mechanism, and Management

  2020cites this paper
• Hemostatic Aspect of Sepsis

  2020cites this paper
• Pathogenetically substantiated prevention of cerebrovascular disorders in patients with coronavirus disease

  2020cites this paper
• Hyperthrombotic Milieu in COVID-19 Patients

  2020cites this paper
• Thrombotic Microangiopathy in Cancer

  2019cites this paper
• Effects of cerium oxide nanoparticles on hemostasis: Coagulation, platelets, and vascular endothelial cells.

  2019cites this paper
• Extracorporeal life support and systemic inflammation

  2019cites this paper
• Pathophysiology 1. Mechanisms of Thrombosis in Cancer Patients.

  2019cites this paper
• Toll‐like receptors 2 and 7 mediate coagulation activation and coagulopathy in murine sepsis

  2019cites this paper
• Crosstalk of Inflammation and Coagulation in Infectious Disease and Their Roles in Disseminated Intravascular Coagulation

  2019cites this paper
• Expression of flTF and asTF splice variants in various cell strains and tissues

  2019cites this paper
• Elevated Microparticle Tissue Factor Activity Is Associated With Carotid Artery Plaque in HIV-Infected Women

  2019cites this paper
• Deep Vein Thrombosis is Modulated by Inflammation Regulated via Sirtuin 1/NF-κB Signalling Pathway in a Rat Model

  2019cites this paper
• The diagnostic performance of renal function-adjusted D-dimer testing in individuals suspected of having venous thromboembolism

  2019cites this paper
• Endothelial Extracellular Vesicles in Pulmonary Function and Disease.

  2018cites this paper
• Tissue Factor: An Essential Mediator of Hemostasis and Trigger of Thrombosis

  2018cites this paper
• The role of platelets in acute kidney injury

  2018cites this paper
• Thrombotic microangiopathy in cancer.

  2018cites this paper
• Clinical characteristics, risk factors, and outcomes of usual and unusual site venous thromboembolism

  2018cites this paper
• Genistein has the function of alleviating and treating disseminated intravascular coagulation caused by lipopolysaccharide

  2018cites this paper
• MicroRNA-19a contributes to the epigenetic regulation of tissue factor in diabetes

  2018cites this paper
• The neutrophil to lymphocyte ratio in patients supported with extracorporeal membrane oxygenation

  2018cites this paper
• Аспекты методологии лабораторных исследований гемостаза в детской гематологии-онкологии и общие подходы в патологии гемостаза при лейкозах

  2018cites this paper
• Tissue factor: newer concepts in thrombosis and its role beyond thrombosis and hemostasis.

  2018cites this paper
• Аspects of the methodology of laboratory studies of hemostasis in pediatric hematology-oncology and general approaches in the pathology of hemostasis in leukemia

  2018cites this paper
• Endothelial Cell-derived Extracellular Vesicles Size-dependently Exert Procoagulant Activity Detected by Thromboelastometry

  2017cites this paper
• Interplay between alternatively spliced Tissue Factor and full length Tissue Factor in modulating coagulant activity of endothelial cells.

  2017cites this paper
• Letter to the Editor: Tissue factor of endothelial origin: Just another brick in the wall?

  2017cites this paper
• The significance of some growth factors in the pathogenesis of endocrine ophthalmopathy

  2017influential citation
• C 1 esterase inhibitor mediated protection from acute lung injury

  2017cites this paper
• The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology

  2016cites this paper